Clincosm LogoSign in Get a demo

fallopian tube

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Epithelial Ovarian, Fallopian Tube, Primary Peritoneal Cancer Trial in Houston (Paclitaxel/Bev (control), Paclitaxel/Bev + ZA

Recruiting
  • Epithelial Ovarian
  • +2 more
  • Paclitaxel/Bev (control)
  • Paclitaxel/Bev + ZA (experimental)
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

Ovarian Cancer, Fallopian Tube, Primary Peritoneal Cancer Trial in Birmingham (mirvetuximab soravtansine (MIRV; IMGN853))

Recruiting
  • Ovarian Cancer
  • +2 more
  • mirvetuximab soravtansine (MIRV; IMGN853)
  • Birmingham, Alabama
    University of Alabama at Birmingham Womens & Infants Center
Jun 30, 2022

High Grade Serous Ovarian, Fallopian Tube, Primary Peritoneal Cancer Trial in New York (Carboplatin and Paclitaxel, Nivolumab,

Active, not recruiting
  • High Grade Serous Ovarian
  • +2 more
  • Carboplatin and Paclitaxel
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 13, 2022

Advanced Epithelial Ovarian, Recurrent Epithelial Ovarian, Fallopian Tube Trial in United States (Enzalutamide)

Completed
  • Advanced Epithelial Ovarian
  • +3 more
  • Basking Ridge, New Jersey
  • +5 more
Mar 4, 2022

Fallopian Tube, Primary Peritoneal Cancer, Solid Tumors (e.g. Breast, Ovarian, Prostate, or Pancreatic) and Ovarian Trial in

Completed
  • Fallopian Tube
  • +2 more
  • Groningen, Netherlands
  • +2 more
Dec 28, 2017

Ovarian Cancer, Fallopian Tube, Primary Peritoneal Trial in New York (Positron Emission Tomography, 18F-Fluoro-2-deoxy-D-lucose,

Completed
Has Results
  • Ovarian Cancer
  • +2 more
  • Positron Emission Tomography
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 3, 2017